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1607-551X/Copyright ª 2014, KaohsiuAbstract The aim of this study was to investigate the diagnostic values of conventional ultra-
sound and contrast-enhanced ultrasound (CEUS) in benign and malignant thyroid nodules with
calcification. Conventional ultrasound and CEUS were performed in 122 patients with thyroid
nodules with calcification. The thyroid nodules were characterized as benign or malignant by
pathological diagnosis. The sensitivity, specificity, positive predictive value, negative predic-
tive value, and diagnostic accordance rate of the two imaging methods were determined.
The area under the receiver operating characteristics curve (AUC) was used to assess the diag-
nostic values of the two imaging methods. In 122 cases of thyroid nodules with calcification, 73
benign nodules and 49 malignant nodules were verified by pathological diagnosis. The sensi-
tivity, specificity, positive predictive value, negative predictive value, and diagnostic accor-
dance rate of conventional ultrasound were 50%, 77%, 59%, 69%, and 66%, respectively, and
those of CEUS were 90%, 92%, 88%, 93%, and 91%, respectively. There were significant differ-
ences between the two imaging methods. AUCs of conventional ultrasound and CEUS were
0.628  0.052 and 0.908  0.031, suggesting low and high diagnostic values, respectively. CEUS
has high diagnostic values, being significantly greater than those of conventional ultrasound, in
differential diagnosis of benign and malignant thyroid nodules with calcification.
Copyright ª 2014, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.eclare no conflicts of interest.
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In clinical practice, the incidence of thyroid nodules is high.
Thyroid nodules are found in 50% of autopsy cases [1], and
approximately 5% of these nodules are malignant [2]. Kuhn
et al [3] reported that thyroid papillary carcinoma is the
most common type of thyroid carcinoma, accounting for
more than 85% of thyroid carcinomas. Ultrasound is the
preferred examination method for thyroid diseases [4], and
thyroid nodules with calcification are often detected with
this modality. Previous studies have shown that calcifica-
tion occurs in 19.8e32.1% of thyroid nodules [5,6]. As re-
ported by Kim et al [7], the calcification rates in malignant
and benign thyroid nodules are approximately 40.2% and
22.2%, respectively. In malignant thyroid nodules, the
microcalcification and massive calcification rates are 42.9%
and 26.7% [7]. Therefore, to avoid unnecessary surgery, a
reliable method for identification of the malignant lesions
in a large number of thyroid nodules with calcification is the
focus of clinical attention [8].
Many researchers have attempted to distinguish benign
and malignant thyroid nodules according to the calcifica-
tion type [9,10]. However, because calcification may occur
both in benign and malignant nodules, the application of
conventional ultrasound in diagnosis of thyroid nodules has
been restricted. Contrast-enhanced ultrasound (CEUS) is a
new technology developed in recent years and has yielded
favorable results in the examination of parenchymal organs
such as abdominal organs [11e13], but its application in
thyroid diseases is still in the exploratory stage. In this
study, the diagnostic value of CEUS in identifying benign
and malignant thyroid nodules with calcification was
investigated. The objective was to assist clinicians in
selecting the correct therapeutic approach for thyroid
nodules.Methods
Patients
One hundred and twenty-two patients who underwent
surgery for thyroid nodules with calcification at our hospital
between February 2010 and March 2012 were enrolled in
this study. There were 37 male and 85 female patients,
aged 18e72 years, with an average age of 46  12 years.
There were 122 thyroid nodules, one nodule in each pa-
tient. The nodule size was 0.35e4.2 cm, with an average of
1.5  0.40 cm, and the maximum major diameter of the
calcification lesions was 10 mm. According to the patho-
logical diagnosis results, the 122 thyroid nodules were
divided into a malignant group (49 nodules) and a benign
group (73 nodules).
Methods
An ACUSON Sequoia 512 (Siemens Healthcare, Erlangen,
Germany) ultrasound scanner was used in the present
study. The scanner was equipped with a model 15L8w high-
frequency linear transducer array. The scanner has a spatial
resolution of 0.1 mm. Contrast pulse sequencing (CPS) witha transmitting frequency of 7.0 MHz and a mechanical index
(MI) of 0.32 was used, as recommended, for CEUS pro-
cedures [14].
The SonoVue (Bracco SpA, Milan, Italy) contrast agent
was used for all patients. The agent was prepared by mixing
with 5 mL saline and shaking vigorously until a milky-white
microbubble suspension was obtained. A bolus injection of
2.4 mL of the SonoVue preparation was administered via
the cubital vein, followed by injection of 5 mL saline to
flush the syringe. Immediately thereafter, real-time har-
monic gray-scale ultrasound examination of the thyroid
nodule was conducted, and the dynamic images were
recorded. Finally, the ultrasound images were indepen-
dently evaluated by two experienced sonographers.
CEUS results were categorized as follows. (1) According to
the comparison of echo intensity at peak enhancement be-
tween the thyroid nodule and the surrounding thyroid pa-
renchyma, theenhancementdegreewascategorizedashypo-
enhancement, iso-enhancement, or hyper-enhancement. (2)
According to the uniformity of echo intensity of the lesion at
peak enhancement, the enhancement uniformity was cate-
gorized as homogeneous enhancement or inhomogeneous
enhancement (including local nonenhancement). Quantita-
tive parameters of CEUS, including time to enhancement,
time to peak, and peak intensity, were obtained using 2D
Cardiac Performance Analysis (CPA)magnetic resonance (MR)
quantification software (TomTec Imaging Systems, Unters-
chleissheim, Germany) [15]. According to Zhou et al [16],
inhomogeneous hypo-enhancement was defined as the diag-
nostic standard for malignant thyroid nodules.
Statistical analysis
Data were expressed as mean  SD. Statistical analysis was
performed using SPSS 18.0 statistical software (SPSS Inc.,
Chicago, IL, USA). The t test and Chi-square test were per-
formed for analyzing the measurement data and enumera-
tion data, respectively. A p value <0.05 was considered
statistically significant. The pathologically diagnosed
malignant thyroid nodules were used as standards, and the
receiver operating characteristics (ROC) curves of multi-
variate observations were drawn, with the sensitivity of the
malignant nodule imaging diagnosis as ordinate and
1-specificity as abscissa.
Results
CEUS findings in benign and malignant thyroid
nodules
In the malignant group, all 49 thyroid nodules were papillary
carcinomas, including 44 nodules with microcalcification
and five nodules with coarse calcification. After the injec-
tion of contrast agent, 29 nodules with microcalcification
and two nodules with coarse calcification were categorized
as inhomogeneous hypo-enhancement (Fig. 1). Thirteen
nodules with microcalcification displayed inhomogeneous
hypo-enhancement with penetration of contrast agent into
the surrounding thyroid parenchyma and point-like appear-
ance of contrast agent in the center of the nodule. Two
nodules with microcalcification and two nodules with coarse
Figure 1. Contrast-enhanced ultrasound of thyroid papillary carcinoma.
140 J. Jiang et al.calcification were categorized as iso-enhancement, and one
nodule with coarse calcification as hyper-enhancement.
In the benign group, there were 11 cases of thyroid ade-
noma and 62 cases of nodular goiter. In the 11 cases of thy-
roid adenoma, there were 10 cases with coarse calcification
and 1 case with microcalcification. In the 62 cases of nodular
goiter, 46 and 16 cases had coarse calcification and micro-
calcification, respectively. All 11 cases of thyroid adenoma
were categorized as homogeneous hyper-enhancement, and
the enhancement degree was higher than that of theFigure 2. Contrast-enhanced ultrasound ofsurrounding thyroid parenchyma (Fig. 2). In the 46 cases of
nodular goiter with coarse calcification, 37, seven, and two
cases were categorized as homogeneous iso-enhancement
(Fig. 3), homogeneous hyper-enhancement, and inhomoge-
neous hypo-enhancement, respectively. In the 16 cases of
nodular goiter with microcalcification, nine, three, and four
cases were categorized as homogeneous iso-enhancement,
homogeneous hyper-enhancement, and inhomogeneous
hypo-enhancement, respectively. The Chi-square test re-
sults (c2 Z 80.75, p < 0.001) showed that there was athyroid adenoma with coarse calcification.
Figure 3. Contrast-enhanced ultrasound of nodular goiter with coarse calcification.
CEUS in calcified thyroid nodules 141significant difference in enhancement degree in CEUS be-
tween benign and malignant thyroid nodules (Table 1).Comparisons of quantitative parameters in CEUS
between benign and malignant thyroid nodules
Results of CEUS quantitative parameters showed that there
was no significant difference in time to enhancement and
time to peak between benign and malignant nodules. The
peak intensities between benign and malignant nodules
were statistically different (p < 0.05) (Table 2).Indexes of conventional ultrasound and CEUS in
diagnosis of thyroid nodules
The sensitivity, specificity, positive predictive value,
negative predictive value, and diagnostic accordance rate
of conventional ultrasound were 50%, 77%, 59%, 69%, and
66%, respectively, and those of CEUS were 90%, 92%, 88%,
93%, and 91%, respectively. There were significantTable 1 Comparison of enhancement degree in contrast-enhanc
Pathological type Coarse calcification Microcalcification
h
Papillary carcinoma 5 44
Adenoma 10 1
Nodular goiter 46 16
* There was a significant difference of enhancement degree in CEU
p < 0.001).differences between the two imaging methods (p < 0.05)
(Table 3).ROC curves of conventional ultrasound and CEUS in
the diagnosis of thyroid nodules
In conventional ultrasound, the area under the ROC curve
(AUC), standard error, 95% confidence interval, and p value
were 0.628, 0.052, 0.526e0.731, and 0.016, respectively. In
CEUS, the AUC, standard error, 95% confidence interval,
and p value were 0.908, 0.031, 0.847e0.969, and < 0.001,
respectively (Fig. 4).Discussion
Thyroid calcification is divided into coarse calcification and
microcalcification. On CEUS of thyroid nodules with calci-
fication, malignant nodules are characterized by inhomo-
geneous hypo-enhancement, and benign nodules by








S between benign and malignant thyroid nodules (c2 Z 80.75,
Table 2 Comparison of quantitative parameters in contrast-enhanced ultrasound between benign and malignant thyroid
nodules [mean  standard deviation (SD)].
Group Time of enhancement beginning (s) Time to peak (s) Peak intensity (%)
Benign 12.20  3.46 18.30  4.87 85.58  10.76
Malignant 13.13  4.32 21.37  5.11 41.40  14.10
t 1.852 1.866 27.516
p 0.065 0.063 0.000
142 J. Jiang et al.In this study, there were 49 nodules in the malignant
group, which were all diagnosed as papillary carcinoma on
pathological examination. Of these, 44 cases had micro-
calcification, of which 42 were categorized as inhomoge-
neous hypo-enhancement on CEUS. This finding concurs
with the results of Bartolotta et al [17], who reported that
eight of 15 malignant nodules showed no or weak
enhancement and were categorized as inhomogeneous.
One reason for this finding may be that the calcified bodies
(psammoma bodies) with hard texture in papillary carci-
noma can affect tumor angiogenesis [7]. Thus, the absolute
tumor microvessel density is decreased, leading to poor
blood supply. Another reason is that, although there are
numerous new vessels in tumor tissue, the tortuosity and
irregularity of new vessels and malignant growth of the
tumor destroys many tissue structures including blood
vessels. The degree of vascular necrosis exceeds angio-
genesis; thus, the enhancement degree of malignant nod-
ules is significantly reduced, with manifestation of
inhomogeneous hypo-enhancement on CEUS. In addition,
interstitial fibrosis often occurs in thyroid papillary carci-
noma, further reducing the number of vessels in the nodule
[18]. In the benign group, there were 62 cases of nodular
goiter and 11 cases of adenoma, suggesting that benign
thyroid nodules with calcification are mainly nodular goi-
ters (62/73). This is consistent with the observations re-
ported by Seiberling et al [19] and Khoo et al [20] that
angiographic manifestations are related to the pathological
type of nodules. The nodular goiter is characterized by
homogeneous iso-enhancement. The reason is that the
nodular goiter has no fibrous capsule, and there is no
obvious difference in vascular distribution between the
nodule and the surrounding thyroid tissue. The internal
blood flow status and perfusion of nodular goiters are close
to those in normal thyroid tissue [18]. In this study, six cases
of nodular goiter were categorized as inhomogeneous hypo-
enhancement. The finding of inhomogeneous hypo-Table 3 Indexes of conventional ultrasound and contrast-enha






Malignant 24 17 48.
CEUS Benign 25 56
Malignant 44 6 89.
Benign 5 67
* p < 0.05 compared with conventional ultrasound.enhancement in this benign tumor type is related to the
lesion development pattern of nodular goiter. At the late
hyperplasia stage of nodular goiter, liquefaction, necrosis,
and hemorrhage in parts of the thyroid gland and long-term
compression of nodules lead to the above manifestations.
The results of this study show that thyroid adenoma is
characterized mainly by homogeneous hyper-
enhancement. The main reason is that the adenoma has a
complete capsule, with surrounding rich and thick vessels,
resulting in relatively abundant blood supply and perfusion
compared with normal thyroid tissue. This study also found
that, in thyroid nodules with calcification, the malignant
nodules are characterized mainly by inhomogeneous hypo-
enhancement. Zhang et al [21] found that inhomogeneous
enhancement is strongly suggestive of a malignant nodule,
which was also evident in this study. The angiographic
characteristics of benign and malignant nodules are obvi-
ously different, with significant differences in peak in-
tensity in CEUS between them.
Calcification is very common in thyroid nodular disease,
and the occurrence of microcalcification in malignant thy-
roid nodules is high. It is generally believed that micro-
calcification with a maximum diameter of 2 mm is one of
the morphological features of thyroid papillary carcinoma
[22,23]. However, calcium oxalate crystals can form in
nodular goiters and thyroid adenomas, and manifest as
microcalcification on imaging studies. In this study, 16 cases
of nodular goiter and one case of thyroid adenoma had
microcalcification. In 49 cases of papillary carcinoma, 44
cases had microcalcification. This indicates that micro-
calcification may occur both in benign and malignant thy-
roid nodules. So differentiation of benign and malignant
nodules with conventional ultrasound is restricted. CEUS
technology has provided a new way of identifying benign
and malignant thyroid nodules. However, image interpre-
tation in CEUS is affected by visual resolution and subjec-
tive factors. In CEUS quantitative analysis technology, thenced ultrasound (CEUS) in diagnosis of thyroid nodules.
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Figure 4. Receiver operating characteristic (ROC) curves of
conventional ultrasound and CEUS in diagnosis of thyroid
nodules.
CEUS in calcified thyroid nodules 143changes in contrast agent perfusion with time can be
visualized using a timeeintensity curve [24,25], and the
quantitative parameters including time to enhancement,
time to peak, and peak intensity can be obtained.
Compared with the conventional differential diagnosis
method dependent on nodular morphological and blood
flow observation, CEUS quantitative analysis provides
additional valuable information [26,27]. In this study, the
CEUS data of thyroid nodules were analyzed using TomTec
2D CPA MR quantification software. The results showed that
the time to enhancement and time to peak were greater in
malignant nodules than in benign nodules, and that the
peak intensity of malignant nodules was lower than that of
benign nodules (p < 0.05). While the time to enhancement
and time to peak had no statistical significance (p > 0.05) in
the benign and malignant thyroid nodules, the peak in-
tensity played an important role in the diagnosis of thyroid
nodules in this study.
Thyroid fine needle aspiration (FNA) is usually recom-
mended prior to thyroid nodule resection, and in many in-
stitutions, it is always recommended for solitary nodules,
regardless of the ultrasound findings of these nodules.
However, approximately 2e3% of suspected malignant
nodules are pathologically proven benign by FNA [28], and
7e10% cannot be diagnosed by FNA. Even repeated punc-
ture fails to obtain diagnostic cytological results in 5e7% of
cases [29]. CEUS provides a basis for determining which
thyroid nodules should undergo FNA. It also aids in judging
whether the nodules with suspected cytological results
need repeated biopsy.
This study had several limitations. The malignant nod-
ules were all papillary carcinomas, with no medullary car-
cinomas or undifferentiated carcinomas. Further, nodular
goiters were the main type of benign nodule. This study
therefore does not represent all pathological types of thy-
roid nodule. In further research, all pathological types ofthyroid nodule with a large sample size should be collected
for analyzing the CEUS features.
In conclusion, in the diagnosis of thyroid nodules with
calcification, inhomogeneous hypo-enhancement in CEUS
indicates malignant thyroid nodules, and homogeneous
hyper-enhancement and iso-enhancement suggest benign
nodules. CEUS is a valuable diagnostic tool in distinguishing
benign and malignant thyroid nodules with calcification.References
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